RE:article - Liminal BioSciences making headway in strategic trYou are seriously basing your investment into this company, not on experienced knowledge investors, but an obscure IR company’s pump called BioTuesday. It’s ok if you want to stick your head in the sand but stop attempting to influence others here to believe that you know something, anything. Nothing you say is credible and continually proven wrong. What’s in it for you to intentionally deceive as this paid outlet?
This is a description of the company that you are basing your trust in. Keep it to yourself Newcamostocky. Enough with the pompon cheering nonsense.
BioTuesdays is published by Kilmer Lucas, one of North America’s leading healthcare-only investor relations firms. Kilmer Lucas employs a unique “outsourced in-house” partnership model, taking a holistic approach to building customized IR strategies. Kilmer Lucas leverages its longstanding relationships and strong track record to positively influence investor perceptions, maximize stock valuations and lower the cost of capital needed to fund clients' growth. IR firm article